Metanephric adenoma of the kidney: clinical case and literature review
E. V. Grebenkin,
A. M. Pshikhachev,
B. E. Osmolovskiy,
A. A. Epishkina,
E. Yu. Kozhevnikova,
N. I. Sorokin,
A. A. Kamalov https://doi.org/10.17650/1726-9776-2023-19-3-119-125
Abstract
Metanephric adenoma is a rare benign kidney tumor with a favorable prognosis. These neoplasms are often interpreted as malignant at the preoperative stage, since they do not have specific characteristics showing during instrumental imaging methods, which leads to excessive surgical treatment in the context of nephrectomy volume. Therefore, histological verification is the gold standard for diagnosis. The morphological features of metanephric adenoma are in many ways similar to such kidney tumors as papillary renal cell carcinoma and nephroblastoma (Wilms’ tumor), so sometimes additional research methods are required, including immunohistochemical and molecular genetic ones. In this article, we report a rare clinical case of metanephric adenoma in a forty-seven-year-old woman. The results of clinical and instrumental exams, as well as morphological features of the tumor are presented. A review of the literature on the clinical, morphological, and molecular aspects of this tumor is also presented.
About the Authors
E. V. Grebenkin
UNIM; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Russian Federation
Competing Interests:
Russian Federation
Evgeniy V. Grebenkin.
Build. 6, 26 Podsosenskiy Pereulok, Moscow 101000; 31 Kashirskoe Shosse, Moscow 115409
Competing Interests:
None
A. M. Pshikhachev
K+31 Clinic; M.V. Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Build. 4, 42 Lobachevskogo St., Moscow 119415; Build. 1, 27 Lomonosovskiy Prospekt, Moscow 119192
Competing Interests:
None
B. E. Osmolovskiy
K+31 Clinic
Russian Federation
Competing Interests:
Russian Federation
Build. 4, 42 Lobachevskogo St., Moscow 119415
Competing Interests:
None
A. A. Epishkina
UNIM; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
Russian Federation
Competing Interests:
Russian Federation
Build. 6, 26 Podsosenskiy Pereulok, Moscow 101000; 31 Kashirskoe Shosse, Moscow 115409
Competing Interests:
None
E. Yu. Kozhevnikova
UNIM
Russian Federation
Competing Interests:
Russian Federation
Build. 6, 26 Podsosenskiy Pereulok, Moscow 101000
Competing Interests:
None
N. I. Sorokin
M.V. Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Build. 1, 27 Lomonosovskiy Prospekt, Moscow 119192
Competing Interests:
None
A. A. Kamalov
K+31 Clinic; M.V. Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Build. 4, 42 Lobachevskogo St., Moscow 119415; Build. 1, 27 Lomonosovskiy Prospekt, Moscow 119192
Competing Interests:
None
References
1. Pages A., Granier M. Nephrogenic nephroma. Arch Anat Cytol Pathol 1980;28(2):99-103.
2. Bastide C., Rambeaud J.J., Bach A.M., Russo P. Metanephric adenoma of the kidney: clinical and radiological study of nine cases. BJU Int 2009;103:1544-8. DOI: 10.1111/j.1464-410X.2009.08357.x
3. Paner G.P., Turk T.M., Clark J.I. et al. Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch Pathol Lab Med 2005;129(10):1317-21. DOI: 10.5858/2005-129-1317-PSIMAA
4. Renshaw A.A., Freyer D.R., Hammers Y.A. Metastatic metanephric adenoma in a child. Am J Surg Pathol 2000;24(4):570-4. DOI: 10.1097/00000478-200004000-00012
5. Drut R., Drut R.M., Ortolani C. Metastatic metanephric adenoma with foci of papillary carcinoma in a child: a combined histologic, immunohistochemical, and FISH study. Int J Surg Pathol 2001;9(3):241-7. DOI: 10.1177/106689690100900313
6. Choueiri T.K., Cheville J., Palescandolo E. et al. BRAF mutations in metanephric adenoma of the kidney. Eur Urol 2012;62(5):917-22. DOI: 10.1016/j.eururo.2012.05.051
7. Udager A.M., Pan J., Magers M.J. et al. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma. Am J Surg Pathol 2015;39(4):549-57. DOI: 10.1097/PAS.0000000000000377
8. Kinney S.N., Eble J.N., Hes O. et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol 2015;28(9):1236-48. DOI: 10.1038/modpathol.2015.81
9. Wobker S.E., Matoso A., Pratilas C.A. et al. Metanephric adenoma-epithelial wilms tumor overlap lesions: an analysis of BRAF status. Am J Surg Pathol 2019;43(9):1157-69. DOI: 10.1097/PAS.0000000000001240
10. Muir T.E., Cheville J.C., Lager D.J. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. Am J Surg Pathol 2001;25(10):1290-6. DOI: 10.1097/00000478-200110000-00010
11. Wang P., Tian Y., Xiao Y. et al. A metanephric adenoma of the kidney associated with polycythemia: a case report. Oncol Lett 2016;11(1): 352-4. DOI: 10.3892/ol.2015.3868
12. Jiang T., Li W., Lin D. et al. Imaging features of metanephric adenoma and their pathological correlation. Clin Radiol 2019;74(5): 408.e9-17. DOI: 10.1016/j.crad.2019.01.013
13. Zhu D., Zhu L., Wu J. et al. Metanephric adenoma: association between the imaging features of contrast-enhanced ultrasound and clinicopathological characteristics. Gland Surg 2021;10(8):2490-9. DOI: 10.21037/gs-21-437
14. Torricelli F.C., Marchini G.S., Campos R.S. et al. Metanephric adenoma: clinical, imaging, and histological findings. Clinics (Sao Paulo) 2011;66(2):359-61. DOI: 10.1590/S1807-59322011000200030
15. Li G., Fu F., Song H. et al. Computed tomography imaging spectrum and the histopathological features of adult metanephric adenoma. Br J Radiol 2015;88(1051):20140807. DOI: 10.1259/bjr.20140807
16. Delzongle M., Boukamel S., Kemeny F. et al. Metanephric adenoma: MR imaging features with histopathological correlation. Diagn Interv Imaging 2015;96(4):387-90. DOI: 10.1016/j.diii.2014.11.005
17. Yan J., Cheng J.L., Li C.F. et al. The findings of CT and MRI in patients with metanephric adenoma. Diagn Pathol 2016;11(1):104. DOI: 10.1186/s13000-016-0535-x
18. WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. In: WHO Classification of Tumours Series. 5th edn. Vol. 8. Lyon (France): International Agency for Research on Cancer, 2022. Available at: https://publications.iarc.fr/610.
19. Kastan R., Zizlavska M. Metanephric adenoma. A case report and literature review. Cesk Patol 2019;55(3):165-9.
20. Zhang W., Song Y., Cui H., Zhang Y. Metanephric adenoma of the kidney: a case report and literature review. Asian J Surg 2023;46(6):2319-20. DOI: 10.1016/j.asjsur.2022.12.030
21. Saremian J., Kubik M.J., Masood S. Cytologic features of metanephric adenoma of the kidney: case report and review of the literature. Lab Med 2015;46(2):153-8. DOI: 10.1309/LMW2MHDM6EILGQH2
22. Rodriguez-Zarco E., Machuca-Aguado J., Madas-Garda L. et al. Metanephric adenoma: molecular study and review of the literature. Oncotarget 2022;13:387-92. DOI: 10.18632/oncotarget.28192
23. Brown J.A., Anderl K.L., Borell T.J. et al. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J Urol 1997;158(2):370-4. DOI: 10.1016/S0022-5347(01)64482-3
24. Cossu-Rocca P., Eble J.N., Delahunt B. et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006;19(4):488-93. DOI: 10.1038/modpathol.3800565
25. Calio A., Eble J.N., Hes O. et al. Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation. Oncotarget 2016;8(33):54096-105. DOI: 10.18632/oncotarget.11117
26. Ding Y., Wang C., Li X. et al. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases. Diagn Pathol 2018;13(1):54. DOI: 10.1186/s13000-018-0732-x
27. Catic A., Kurtovic-Kozaric A., Sophian A. et al. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. BMC Med Genet 2020;21(1):202. DOI: 10.1186/s12881-020-01143-6
28. Chan E., Stohr B.A., Croom N.A. et al. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution. Histopathology 2020;76(7):1084-90. DOI: 10.1111/his.14094
29. Lenci N., Francesco P., Scarciglia E. et al. Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process. Med Mol Morphol 2021;54(2):187-91. DOI: 10.1007/s00795-020-00269-z
30. Li G., Tang Y., Zhang R. et al. Adult metanephric adenoma presumed to be all benign? A clinical perspective. BMC Cancer 2015;15:310. DOI: 10.1186/s12885-015-1211-3
Review
For citations:
Grebenkin E.V., Pshikhachev A.M., Osmolovskiy B.E., Epishkina A.A., Kozhevnikova E.Yu., Sorokin N.I., Kamalov A.A. Metanephric adenoma of the kidney: clinical case and literature review. Cancer Urology. 2023;19(3):119-125. (In Russ.) https://doi.org/10.17650/1726-9776-2023-19-3-119-125
Views:
1694
Email this article 